 Sheri Johnson
Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bipolar Disorder | 45 | 2026 | 281 | 11.300 |
Why?
| | Impulsive Behavior | 23 | 2025 | 146 | 7.410 |
Why?
| | Emotions | 22 | 2026 | 578 | 4.420 |
Why?
| | Affect | 18 | 2026 | 322 | 1.770 |
Why?
| | Reward | 10 | 2021 | 247 | 1.520 |
Why?
| | Personality | 6 | 2018 | 132 | 1.490 |
Why?
| | Creativity | 4 | 2026 | 18 | 1.450 |
Why?
| | Motivation | 8 | 2019 | 612 | 1.320 |
Why?
| | Rumination, Cognitive | 2 | 2025 | 11 | 1.110 |
Why?
| | Suicidal Ideation | 4 | 2026 | 577 | 1.100 |
Why?
| | Achievement | 4 | 2015 | 57 | 0.950 |
Why?
| | Social Behavior | 3 | 2018 | 288 | 0.890 |
Why?
| | Self Report | 10 | 2022 | 873 | 0.880 |
Why?
| | Psychopathology | 3 | 2023 | 56 | 0.880 |
Why?
| | Mood Disorders | 2 | 2016 | 140 | 0.860 |
Why?
| | Cognitive Dysfunction | 2 | 2023 | 465 | 0.840 |
Why?
| | Quality of Life | 5 | 2024 | 3197 | 0.830 |
Why?
| | Borderline Personality Disorder | 2 | 2015 | 14 | 0.830 |
Why?
| | Diet, Mediterranean | 1 | 2024 | 28 | 0.820 |
Why?
| | Interpersonal Relations | 3 | 2018 | 400 | 0.800 |
Why?
| | Social Dominance | 2 | 2021 | 18 | 0.780 |
Why?
| | Affective Symptoms | 2 | 2015 | 53 | 0.750 |
Why?
| | Young Adult | 28 | 2026 | 14163 | 0.690 |
Why?
| | Prefrontal Cortex | 3 | 2024 | 328 | 0.680 |
Why?
| | Male | 55 | 2026 | 72628 | 0.650 |
Why?
| | Cognitive Remediation | 1 | 2020 | 4 | 0.630 |
Why?
| | Adult | 43 | 2026 | 40627 | 0.630 |
Why?
| | Humans | 80 | 2026 | 145305 | 0.630 |
Why?
| | Female | 53 | 2026 | 78605 | 0.610 |
Why?
| | Anticipation, Psychological | 1 | 2019 | 20 | 0.600 |
Why?
| | Imagination | 1 | 2019 | 21 | 0.600 |
Why?
| | Life Change Events | 3 | 2015 | 147 | 0.590 |
Why?
| | Suicide, Attempted | 3 | 2026 | 422 | 0.590 |
Why?
| | Prejudice | 1 | 2019 | 60 | 0.580 |
Why?
| | Goals | 4 | 2015 | 184 | 0.560 |
Why?
| | Psychiatric Status Rating Scales | 11 | 2021 | 541 | 0.560 |
Why?
| | Aggression | 3 | 2015 | 179 | 0.550 |
Why?
| | Nucleus Accumbens | 1 | 2019 | 135 | 0.550 |
Why?
| | Social Environment | 3 | 2018 | 254 | 0.550 |
Why?
| | Cyclothymic Disorder | 2 | 2015 | 5 | 0.550 |
Why?
| | Tryptophan | 1 | 2019 | 182 | 0.550 |
Why?
| | Brain Mapping | 3 | 2019 | 537 | 0.540 |
Why?
| | Depression | 8 | 2021 | 1561 | 0.520 |
Why?
| | Mental Disorders | 3 | 2023 | 1173 | 0.520 |
Why?
| | Cognition | 2 | 2023 | 1271 | 0.490 |
Why?
| | Attention | 3 | 2012 | 458 | 0.490 |
Why?
| | Thinking | 3 | 2018 | 66 | 0.490 |
Why?
| | Psychotic Disorders | 2 | 2017 | 186 | 0.490 |
Why?
| | Anger | 1 | 2015 | 60 | 0.450 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 4 | 2022 | 62 | 0.450 |
Why?
| | Adolescent | 25 | 2025 | 22507 | 0.440 |
Why?
| | Mental Recall | 2 | 2009 | 222 | 0.440 |
Why?
| | Entrepreneurship | 1 | 2014 | 6 | 0.430 |
Why?
| | Income | 1 | 2015 | 202 | 0.420 |
Why?
| | Arousal | 3 | 2023 | 157 | 0.400 |
Why?
| | Mindfulness | 4 | 2021 | 155 | 0.390 |
Why?
| | Intention | 1 | 2014 | 187 | 0.380 |
Why?
| | Global Health | 1 | 2015 | 403 | 0.360 |
Why?
| | Inpatients | 1 | 2017 | 551 | 0.360 |
Why?
| | Health Status Disparities | 1 | 2015 | 322 | 0.360 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2025 | 1747 | 0.350 |
Why?
| | Circadian Rhythm | 3 | 2024 | 514 | 0.350 |
Why?
| | Adolescent Behavior | 1 | 2017 | 501 | 0.350 |
Why?
| | Behavior | 1 | 2011 | 91 | 0.340 |
Why?
| | Risk Factors | 11 | 2023 | 10816 | 0.320 |
Why?
| | Mental Health Services | 1 | 2016 | 474 | 0.320 |
Why?
| | Decision Making | 1 | 2018 | 980 | 0.320 |
Why?
| | Sleep Wake Disorders | 2 | 2024 | 309 | 0.320 |
Why?
| | Executive Function | 3 | 2025 | 462 | 0.300 |
Why?
| | Depressive Disorder | 3 | 2014 | 387 | 0.300 |
Why?
| | Memory, Short-Term | 4 | 2025 | 271 | 0.290 |
Why?
| | Healthcare Disparities | 1 | 2016 | 736 | 0.290 |
Why?
| | Memory, Episodic | 1 | 2009 | 54 | 0.280 |
Why?
| | Brain-Derived Neurotrophic Factor | 3 | 2015 | 151 | 0.280 |
Why?
| | Middle Aged | 21 | 2026 | 36021 | 0.270 |
Why?
| | Cross-Sectional Studies | 7 | 2022 | 5883 | 0.260 |
Why?
| | Anxiety | 4 | 2021 | 1113 | 0.260 |
Why?
| | Wounds and Injuries | 1 | 2015 | 961 | 0.250 |
Why?
| | Surveys and Questionnaires | 8 | 2021 | 6079 | 0.250 |
Why?
| | Convalescence | 1 | 2007 | 19 | 0.250 |
Why?
| | Pilot Projects | 2 | 2025 | 1894 | 0.250 |
Why?
| | Social Support | 3 | 2018 | 652 | 0.230 |
Why?
| | Suicide | 3 | 2026 | 726 | 0.230 |
Why?
| | Nerve Net | 2 | 2019 | 285 | 0.220 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 5 | 2025 | 232 | 0.220 |
Why?
| | Models, Psychological | 2 | 2017 | 299 | 0.210 |
Why?
| | Gyrus Cinguli | 1 | 2024 | 96 | 0.210 |
Why?
| | Mental Processes | 1 | 2004 | 38 | 0.210 |
Why?
| | Phobic Disorders | 1 | 2004 | 35 | 0.210 |
Why?
| | Galvanic Skin Response | 2 | 2016 | 26 | 0.210 |
Why?
| | Students | 5 | 2023 | 663 | 0.210 |
Why?
| | Risk | 3 | 2015 | 912 | 0.200 |
Why?
| | Personality Assessment | 2 | 2014 | 79 | 0.200 |
Why?
| | Cooperative Behavior | 1 | 2006 | 467 | 0.200 |
Why?
| | Yohimbine | 1 | 2023 | 11 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 4 | 2024 | 3888 | 0.190 |
Why?
| | Fasting | 1 | 2024 | 277 | 0.190 |
Why?
| | Waiting Lists | 1 | 2025 | 263 | 0.190 |
Why?
| | Brain | 4 | 2025 | 2945 | 0.190 |
Why?
| | Personality Inventory | 3 | 2014 | 134 | 0.190 |
Why?
| | Endophenotypes | 1 | 2022 | 21 | 0.180 |
Why?
| | Psychology | 2 | 2020 | 88 | 0.180 |
Why?
| | Antidepressive Agents | 2 | 2020 | 248 | 0.180 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2015 | 2152 | 0.180 |
Why?
| | Clinical Trials as Topic | 2 | 2024 | 1063 | 0.170 |
Why?
| | Heart Rate | 3 | 2016 | 857 | 0.170 |
Why?
| | Social Sciences | 1 | 2020 | 8 | 0.160 |
Why?
| | Patient Care Team | 1 | 2006 | 692 | 0.160 |
Why?
| | Psychotherapy | 2 | 2017 | 191 | 0.160 |
Why?
| | Self-Assessment | 2 | 2019 | 74 | 0.160 |
Why?
| | 5-Hydroxytryptophan | 1 | 2020 | 19 | 0.160 |
Why?
| | Vitamin B 6 | 1 | 2019 | 11 | 0.150 |
Why?
| | Anxiety Disorders | 3 | 2017 | 373 | 0.150 |
Why?
| | Sexism | 1 | 2020 | 70 | 0.150 |
Why?
| | Comorbidity | 4 | 2017 | 1661 | 0.150 |
Why?
| | Perfectionism | 1 | 2019 | 3 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 4 | 2014 | 2371 | 0.140 |
Why?
| | Stress, Psychological | 2 | 2018 | 1153 | 0.140 |
Why?
| | Psychotherapy, Group | 1 | 2019 | 80 | 0.140 |
Why?
| | Personality Tests | 1 | 2018 | 12 | 0.140 |
Why?
| | Racism | 1 | 2021 | 154 | 0.140 |
Why?
| | Pessimism | 1 | 2018 | 9 | 0.140 |
Why?
| | Therapy, Computer-Assisted | 1 | 2018 | 64 | 0.130 |
Why?
| | Psychology, Social | 1 | 2017 | 12 | 0.130 |
Why?
| | Child Abuse | 2 | 2015 | 555 | 0.130 |
Why?
| | Judgment | 1 | 2018 | 66 | 0.130 |
Why?
| | Brain Waves | 1 | 2017 | 45 | 0.130 |
Why?
| | Neuropsychological Tests | 2 | 2025 | 1138 | 0.130 |
Why?
| | Eating | 1 | 2019 | 392 | 0.120 |
Why?
| | Respiratory Sinus Arrhythmia | 1 | 2016 | 14 | 0.120 |
Why?
| | Schizophrenic Psychology | 1 | 2017 | 97 | 0.120 |
Why?
| | Schizophrenia | 1 | 2021 | 446 | 0.120 |
Why?
| | Empathy | 1 | 2019 | 182 | 0.120 |
Why?
| | Leadership | 1 | 2021 | 410 | 0.120 |
Why?
| | Science | 1 | 2017 | 56 | 0.120 |
Why?
| | Recurrence | 1 | 2020 | 1138 | 0.120 |
Why?
| | Alcohol Drinking | 1 | 2023 | 826 | 0.120 |
Why?
| | Neuroimaging | 1 | 2019 | 294 | 0.120 |
Why?
| | Risk Assessment | 2 | 2018 | 3686 | 0.120 |
Why?
| | Trust | 1 | 2018 | 155 | 0.120 |
Why?
| | Choice Behavior | 1 | 2017 | 178 | 0.120 |
Why?
| | Military Personnel | 1 | 2023 | 747 | 0.110 |
Why?
| | Self-Management | 1 | 2018 | 201 | 0.110 |
Why?
| | Receptors, Opioid, mu | 1 | 2015 | 68 | 0.110 |
Why?
| | Antipsychotic Agents | 2 | 2008 | 214 | 0.110 |
Why?
| | Remission Induction | 1 | 2015 | 308 | 0.110 |
Why?
| | Receptors, Dopamine D4 | 1 | 2014 | 26 | 0.110 |
Why?
| | Adult Survivors of Child Adverse Events | 1 | 2014 | 15 | 0.110 |
Why?
| | Genotype | 2 | 2022 | 1845 | 0.110 |
Why?
| | Catechol O-Methyltransferase | 1 | 2014 | 20 | 0.110 |
Why?
| | Case-Control Studies | 5 | 2018 | 3613 | 0.110 |
Why?
| | Tryptophan Hydroxylase | 1 | 2014 | 54 | 0.100 |
Why?
| | Regression Analysis | 2 | 2014 | 1003 | 0.100 |
Why?
| | Gene-Environment Interaction | 1 | 2015 | 182 | 0.100 |
Why?
| | Research | 1 | 2017 | 431 | 0.100 |
Why?
| | Self Concept | 2 | 2014 | 253 | 0.100 |
Why?
| | Receptors, Dopamine D2 | 1 | 2014 | 93 | 0.100 |
Why?
| | Respiration | 2 | 2011 | 207 | 0.100 |
Why?
| | Predictive Value of Tests | 3 | 2011 | 2118 | 0.100 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 1327 | 0.100 |
Why?
| | Learning | 1 | 2017 | 452 | 0.090 |
Why?
| | Frustration | 1 | 2012 | 8 | 0.090 |
Why?
| | Personality Disorders | 2 | 2017 | 79 | 0.090 |
Why?
| | Prevalence | 2 | 2017 | 2838 | 0.090 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2014 | 431 | 0.090 |
Why?
| | Happiness | 1 | 2011 | 23 | 0.080 |
Why?
| | Parasympathetic Nervous System | 1 | 2011 | 26 | 0.080 |
Why?
| | Sleep | 1 | 2018 | 901 | 0.080 |
Why?
| | Epistasis, Genetic | 1 | 2011 | 66 | 0.080 |
Why?
| | Disruptive, Impulse Control, and Conduct Disorders | 1 | 2008 | 10 | 0.070 |
Why?
| | Autonomic Nervous System | 1 | 2009 | 79 | 0.070 |
Why?
| | Social Control, Informal | 1 | 2008 | 21 | 0.070 |
Why?
| | Neurotransmitter Agents | 2 | 2006 | 82 | 0.070 |
Why?
| | Memory | 2 | 2011 | 296 | 0.070 |
Why?
| | Prospective Studies | 3 | 2011 | 8011 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2011 | 612 | 0.070 |
Why?
| | Membrane Proteins | 1 | 2014 | 1169 | 0.070 |
Why?
| | Severity of Illness Index | 2 | 2025 | 2926 | 0.070 |
Why?
| | Family Therapy | 1 | 2008 | 67 | 0.070 |
Why?
| | Vocabulary | 1 | 2007 | 35 | 0.060 |
Why?
| | Serotonin | 1 | 2008 | 294 | 0.060 |
Why?
| | Lithium Compounds | 1 | 2006 | 11 | 0.060 |
Why?
| | Antimanic Agents | 1 | 2006 | 19 | 0.060 |
Why?
| | United States | 3 | 2023 | 16051 | 0.060 |
Why?
| | Hearing Disorders | 1 | 2025 | 10 | 0.060 |
Why?
| | Photography | 1 | 2026 | 116 | 0.060 |
Why?
| | Ecological Momentary Assessment | 1 | 2026 | 47 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2015 | 5431 | 0.060 |
Why?
| | Functional Neuroimaging | 1 | 2025 | 60 | 0.060 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2025 | 70 | 0.050 |
Why?
| | Writing | 1 | 2026 | 103 | 0.050 |
Why?
| | Discrimination Learning | 1 | 2004 | 54 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2025 | 319 | 0.050 |
Why?
| | Verbal Learning | 1 | 2004 | 73 | 0.050 |
Why?
| | Facial Expression | 1 | 2004 | 74 | 0.050 |
Why?
| | Substance-Related Disorders | 1 | 2013 | 1094 | 0.050 |
Why?
| | Pattern Recognition, Visual | 1 | 2004 | 105 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2006 | 243 | 0.050 |
Why?
| | Attitude to Health | 1 | 2006 | 436 | 0.050 |
Why?
| | Individuality | 1 | 2024 | 152 | 0.050 |
Why?
| | Cost of Illness | 1 | 2006 | 322 | 0.050 |
Why?
| | Reading | 1 | 2004 | 136 | 0.050 |
Why?
| | Monoamine Oxidase | 1 | 2022 | 25 | 0.050 |
Why?
| | Patient Compliance | 1 | 2006 | 589 | 0.050 |
Why?
| | Physician-Patient Relations | 1 | 2006 | 588 | 0.040 |
Why?
| | Professional Practice | 1 | 2021 | 57 | 0.040 |
Why?
| | Biological Evolution | 1 | 2024 | 489 | 0.040 |
Why?
| | Psychological Theory | 1 | 2020 | 93 | 0.040 |
Why?
| | Bias | 1 | 2021 | 202 | 0.040 |
Why?
| | Patient Education as Topic | 2 | 2019 | 782 | 0.040 |
Why?
| | Proof of Concept Study | 1 | 2019 | 85 | 0.040 |
Why?
| | Longitudinal Studies | 1 | 2006 | 2959 | 0.040 |
Why?
| | Pupil | 1 | 2018 | 22 | 0.040 |
Why?
| | Netherlands | 1 | 2018 | 82 | 0.030 |
Why?
| | Psychology, Experimental | 1 | 2017 | 1 | 0.030 |
Why?
| | Australia | 1 | 2018 | 287 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2017 | 11731 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2017 | 284 | 0.030 |
Why?
| | Sociological Factors | 1 | 2015 | 6 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 798 | 0.030 |
Why?
| | Genotyping Techniques | 1 | 2015 | 69 | 0.030 |
Why?
| | Child | 1 | 2015 | 22712 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 639 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 315 | 0.030 |
Why?
| | Psychometrics | 1 | 2018 | 736 | 0.030 |
Why?
| | Internet | 1 | 2018 | 701 | 0.020 |
Why?
| | Linear Models | 1 | 2015 | 854 | 0.020 |
Why?
| | Interview, Psychological | 1 | 2013 | 94 | 0.020 |
Why?
| | Universities | 1 | 2015 | 453 | 0.020 |
Why?
| | Communication | 1 | 2017 | 973 | 0.020 |
Why?
| | Alcoholism | 1 | 2017 | 817 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2017 | 3419 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2011 | 373 | 0.020 |
Why?
| | Cohort Studies | 1 | 2020 | 5982 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1311 | 0.020 |
Why?
| | Electrocardiography | 1 | 2011 | 663 | 0.020 |
Why?
| | Antisocial Personality Disorder | 1 | 2008 | 121 | 0.020 |
Why?
| | Vagus Nerve | 1 | 2008 | 91 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2008 | 160 | 0.020 |
Why?
| | Aged | 2 | 2021 | 26001 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 7186 | 0.010 |
Why?
| | Cues | 1 | 2008 | 326 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2008 | 1268 | 0.010 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 428 | 0.010 |
Why?
| | Terminology as Topic | 1 | 2005 | 256 | 0.010 |
Why?
| | Adaptation, Psychological | 1 | 2008 | 717 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 2005 | 1500 | 0.010 |
Why?
| | Research Design | 1 | 2005 | 1137 | 0.010 |
Why?
| | Animals | 1 | 2019 | 38177 | 0.010 |
Why?
|
|
Johnson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|